Public Comment and Testimony

The AIDS Institute Letter Regarding Medicaid Restrictions on Hepatitis C Curative Medications

Today, The AIDS Institute sent this letter to Seema Verma, Administrator of the Centers for Medicare and Medicaid Services, urging her to enforce Medicaid law and compel states to lift their restrictions on hepatitis C drugs. In the letter, The AIDS Institute claims that the price of the drug, which can cure people within eight weeks, cannot be used as an excuse to restrict access.

The AIDS Institute Submits Written Testimony to Senate Appropriations Committee

The AIDS Institute, a national public policy, research, advocacy, and education organization, is pleased to offer testimony in support of domestic HIV/AIDS and hepatitis programs in the FY2018 Labor, Health and Human Services, Education, and Related Agencies appropriation measure. We thank you for your past support, and trust you will do your best to adequately fund these programs in the future to provide for andprotect the health of Americans.

Comments Re: RIN 0938-AT14 Patient Protection and Affordable Care Act; Market Stabilization

The AIDS Institute submitted comments to the Department of Health and Human Services (HHS) on the Patient Protection and Affordable Care Act; Market Stabilization proposed rule.

Read the full comments here.

The AIDS Institute Comments on Arizona Medicaid Changes to Hepatitis C Prior Authorization Requirements

The AIDS Institute submitted comments on Wednesday, September 28, 2016 in response to Arizona Medicaid's proposed changes to their hepatitis C prior authorization policy. The biggest proposed changes included moving from an F score of F3 to F2 and loosening substance use remission restrictions from 6 months to 3 months. Our comments applauded them for taking steps in the right direction, but explained that there is no medical reason to have restrictions in those areas.

TAI submits comments to the DNC and RNC on the 2016 party platforms

Below are The AIDS Institute's written comments on the 2016 party platforms for the Democratic and Republican National Committees 

The AIDS Institute Submits Comments on HHS Listening Session on PrEP

The AIDS Institute presented and offered written testimony to a speical HHS listening session on PrEP. Below are our written comments. 

The AIDS Institute Submits Written Testimony to House and Senate Appropriations Committees

TAI submitted the below written testimony to the House and Senate Appropriations Committees for FY2017

Letter to Secretary Hillary Clinton: The Importance of Addressing Hepatitis C in the United States

In response to recent comments Democratic presidential nominee and former Secretary of State Hillary Clinton made regarding hepatitis C (HCV) and the pricing of new curative drugs, The AIDS Institute sent a letter yesterday urging her to prioritize elimination of hepatitis C as a public health threat should she be elected president.

TAI urges Florida Senators to support H.R. 3700

The AIDS Institute wrote to Sens. Nelson (D-FL) and Rubio (R-FL) urging them to support the Housing Opportunities Through Modernization Act of 2016 (H.R. 3700), which makes important modifications to the Housing Opportunities for Persons with AIDS (HOPWA) program. To see the letters, click the PDFs below: 

The AIDS Institute Submits Written Testimony to the Senate Appropriations Health Committee

March 31, 2015

We have made great progress in the fight against HIV/AIDS, but we are still far from achieving zero new HIV infections, an AIDS-free generation, and eradicating viral hepatitis. We now have the tools, but we need continued leadership from Congress and the necessary resources to realize our goals. To view our testimony, click the PDF link below

Image of the U.S. Senate Seal
Syndicate content